PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 13 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Flavonoids 5,6,4'-trihydroxy-7,8,3'-trimethoxyflavone and 5,6-dihydroxy-7,8,3',4'-tetramethoxyflavone demonstrated high antiallergic activities in vitro with IC50 values of 2.4uM and 3.0uM respectively [PMID:25704366]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 25704366 (2015) — High antiallergic activity of 5,6,4'-trihydroxy-7,8,3'-trimethoxyflavone and 5,6-dihydroxy-7,8,3',4'-tetramethoxyflavone from eau de cologne mint (Mentha×piperita citrata). · Fitoterapia
- 2.PMID: 32876749 (2020) — Enhanced monoterpene emission in transgenic orange mint (Mentha × piperita f. citrata) overexpressing a tobacco lipid transfer protein (NtLTP1). · Planta
- 3.PMID: 12176064 (2002) — Molecular cloning and characterization of a new linalool synthase. · Archives of biochemistry and biophysics
- 4.PMID: 19476006 (2009) — Enantiomeric composition of (3R)-(-)- and (3S)-(+)-linalool in various essential oils of Indian origin by enantioselective capillary gas chromatography-flame ionization and mass spectrometry detection methods. · Natural product communications